Plasma Levels of Soluble AβPPβ as a Biomarker for Alzheimer's Disease with Dementia

被引：1

作者：

Alexopoulos, Panagiotis ^{[1
,2
]}

Thierjung, Nathalie ^{[1
]}

Economou, Polychronis ^{[3
]}

Werle, Lukas ^{[1
,4
]}

Buhl, Felix ^{[1
]}

Kagerbauer, Simone ^{[5
]}

Papanastasiou, Anastasios D. ^{[6
]}

Grimmer, Timo ^{[1
]}

Gourzis, Philippos ^{[2
]}

Berthele, Achim ^{[7
]}

Hemmer, Bernhard ^{[7
,8
]}

Kuebler, Hubert ^{[9
]}

Martin, Jan ^{[5
]}

Politis, Antonios ^{[10
,11
]}

Perneczky, Robert ^{[8
,12
,13
,14
]}

机构：

[1] Tech Univ Munich, Dept Psychiat & Psychotherapy, Klinikum Rechts Isar, Munich, Germany

[2] Univ Patras, Univ Hosp Rion, Dept Psychiat, Patras, Greece

[3] Univ Patras, Dept Civil Engn Stat, Patras, Greece

[4] Max Planck Inst Psychiat, Munich, Germany

[5] Tech Univ Munich, Dept Anaesthesiol, Klinikum Rechts Isar, Munich, Germany

[6] Univ Patras, Mol Oncol Lab, Div Oncol, Univ Hosp Patras, Patras, Greece

[7] Tech Univ Munich, Dept Neurol, Klinikum Rechts Isar, Munich, Germany

[8] Munich Cluster Syst Neurol SyNergy, Munich, Germany

[9] Tech Univ Munich, Dept Urol, Klinikum Rechts Isar, Munich, Germany

[10] Univ Athens, Dept Psychiat 1, Eginit Hosp, Athens, Greece

[11] Johns Hopkins Med Sch, Dept Psychiat, Div Geriatr Psychiat & Neuropsychiat, Baltimore, MD USA

[12] Ludwig Maximilians Univ Munchen, Dept Psychiat & Psychotherapy, Munich, Germany

[13] Imperial Coll Sci Technol & Med, Ageing Epidemiol AGE Res Unit, Sch Publ Hlth, Fac Med, London, England

[14] German Ctr Neurodegenerat Dis DZNE Munich, Munich, Germany

来源：

JOURNAL OF ALZHEIMERS DISEASE | 2019年 / 69卷 / 01期

关键词：

Biomarker candidate; NIA-AA research framework diagnostic criteria; soluble amyloid-beta protein precursor beta; CEREBROSPINAL-FLUID BIOMARKERS; AMYLOID PRECURSOR PROTEINS; MILD COGNITIVE IMPAIRMENT; BACE1; ACTIVITY; CSF; BETA-AMYLOID((1-42)); METABOLISM; CLEARANCE; DECLINE; MARKERS;

D O I：

10.3233/JAD-181088

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

Cost- and time-effective markers of Alzheimer's disease (AD), reliable and feasible at the population level are urgently needed. Soluble amyloid-beta protein precursor beta (sA beta PP beta) in plasma has attracted scientific attention as a potential AD biomarker candidate. Here we report that plasma sA beta PP beta levels in patients with AD dementia and typical for AD cerebrospinal fluid (CSF) biomarker profiles (N = 33) are significantly lower (p < 0.01) than those of cognitively healthy elderly individuals without AD (N = 39), while CSF sA beta PP beta levels did not differ between the studied groups. This provides further evidence for the potential of sA beta PP beta in plasma as an AD biomarker candidate.

引用

页码：83 / 90

页数：8

共 46 条

[1] Alexopoulos P, 2017, EUR ARCH PSY CLIN N, V268, P519
[2] Alexopoulos P, 2018, NEUROMETHODS, V137, P93, DOI 10.1007/978-1-4939-7674-4_6
[3] Cerebrospinal Fluid BACE1 Activity and sAβPPβ as Biomarker Candidates of Alzheimer's Disease
Alexopoulos, Panagiotis
Thierjung, Nathalie
Grimmer, Timo
Ortner, Marion
Economou, Polychronis
Assimakopoulos, Konstantinos
Gourzis, Philippos
Politis, Antonios
Perneczky, Robert
[J]. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2018, 45 (3-4) : 152 - 161
[4] Mapping CSF biomarker profiles onto NIA-AA guidelines for Alzheimer's disease
Alexopoulos, Panagiotis
Roesler, Jennifer
Thierjung, Nathalie
Werle, Lukas
Buck, Dorothea
Yakushev, Igor
Gleixner, Lena
Kagerbauer, Simone
Ortner, Marion
Grimmer, Timo
Kuebler, Hubert
Martin, Jan
Laskaris, Nikolaos
Kurz, Alexander
Perneczky, Robert
[J]. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2016, 266 (07) : 587 - 597
[5] Amyloid Cascade and Tau Pathology Cerebrospinal Fluid Markers in Mild Cognitive Impairment with regards to Alzheimer's Disease Cerebral Metabolic Signature
Alexopoulos, Panagiotis
Guo, Liang-Hao
Jiang, Meizi
Bujo, Hideaki
Grimmer, Timo
Foerster, Stefan
Drzezga, Alexander
Kurz, Alexander
Perneczky, Robert
[J]. JOURNAL OF ALZHEIMERS DISEASE, 2013, 36 (02) : 401 - 408
[6] [Anonymous], COCHRANE DATABASE SY
[7] [Anonymous], 2011, ALZHEIMERS DEMENT, DOI DOI 10.1016/J.JALZ.2011.03.005
[8] Potential value of soluble APP alpha and APP beta in CSF as biomarkers of dementia disorders: Unresolved issues and perspectives
Araki, Wataru
Araki, Yumiko M.
Mizusawa, Hidehiro
[J]. NEUROLOGY AND CLINICAL NEUROSCIENCE, 2018, 6 (04): : 89 - 93
[9] Re-evaluation of soluble APP-α and APP-β in cerebrospinal fluid as potential biomarkers for early diagnosis of dementia disorders
Araki, Wataru
Hattori, Kotaro
Kanemaru, Kazutomi
Yokoi, Yuma
Omachi, Yoshie
Takano, Harumasa
Sakata, Masuhiro
Yoshida, Sumiko
Tsukamoto, Tadashi
Murata, Miho
Saito, Yuko
Kunugi, Hiroshi
Goto, Yu-Ichi
Nagaoka, Utako
Nagao, Masahiro
Komori, Takashi
Arima, Kunimasa
Ishii, Kenji
Murayama, Shigeo
Matsuda, Hiroshi
Tachimori, Hisateru
Araki, Yumiko M.
Mizusawa, Hidehiro
[J]. BIOMARKER RESEARCH, 2017, 5
[10] Soluble amyloid precursor protein α and β in CSF in Alzheimer's disease
Brinkmalm, Gunnar
Brinkmalm, Ann
Bourgeois, Philippe
Persson, Rita
Hansson, Oskar
Portelius, Erik
Mercken, Marc
Andreasson, Ulf
Parent, Stephane
Lipari, Francesco
Ohrfelt, Annika
Bjerke, Maria
Minthon, Lennart
Zetterberg, Henrik
Blennow, Kaj
Nutu, Magdalena
[J]. BRAIN RESEARCH, 2013, 1513 : 117 - 126

← 1 2 3 4 5 →